Navigation Links
Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
Date:8/29/2007

SAN CARLOS, Calif., Aug. 29 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that Mr. Lutz Lingnau has been appointed to serve on its board of directors. Lingnau is a highly-respected pharmaceutical industry leader with over 35 years of experience in corporate management, product development and marketing.

"Lutz Lingnau brings to Nektar extensive pharmaceutical development and commercialization experience at an important point in the company's evolution," said Howard W. Robin, President and CEO of Nektar. "As we continue to drive our proprietary programs through the clinic, it is imperative that we leverage the strategic guidance of leaders like Lutz who have a proven track record of bringing successful therapeutics to market."

Most recently, Lingnau was a member of the Executive Board at Schering AG and Vice Chairman, President and CEO of Schering Berlin, Inc. While at Schering AG, he was responsible for the worldwide specialized therapeutics business and also held a number of other executive positions including Head of Worldwide Sales and Marketing in the Pharmaceutical Division, and Chairman and President of Berlex Laboratories, Inc.

"Nektar's innovative development of therapeutics using its proprietary PEGylation and pulmonary technologies is among the most important areas in biopharmaceutical drug development," Lingnau said. "I look forward to working with Howard and his executive team as they move Nektar's clinical pipeline forward and advance the company's strategic business objectives."

Lingnau is also currently a member of the Supervisory Board of LANXESS AG, Germany and Chairman of the Board of Directors of Micropharma Ltd., Montreal. He was formerly a memb
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Sharon Ethanol appoints operations director
3. Kyron appoints former AMA chairman to board
4. Brady appoints GE efficiency expert as CTO
5. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
6. Johnson Controls appoints Roell to head EOC
7. SecurePipe appoints two senior execs
8. Milwaukees PointOne appoints new president and CEO
9. Third Wave appoints new chairman
10. Midwest Venture Summit disappoints; Cato grades Midwest governors
11. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... - Sales in the First Half of 2009 (Excluding ... - Growth in the Pharma Business, - ... Laboratory Glassware, , In the first ... the continuing worldwide economic crisis. This result was,mainly attributable to sales growth ...
... Mass., July 14 Idenix Pharmaceuticals, Inc., (Nasdaq: IDIX ... the second quarter of 2009 on Monday, July 20, 2009 after ... In conjunction with the issuance of the press release, Idenix management ... July 20, 2009 to discuss the company,s financial results for the ...
... , LAKE ZURICH, Ill., July 14 ... blood collection, separation, safety and availability, announced today it has ... to market, sell and distribute Verax,s unique PanGenera(R) Detection (PGD) ... in donated blood platelets. , ...
Cached Biology Technology:Gerresheimer Holds its own in Difficult Environment 2Gerresheimer Holds its own in Difficult Environment 3Gerresheimer Holds its own in Difficult Environment 4Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test 2Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test 3
(Date:4/15/2014)... viral diseases in the world for which no pharmaceutical ... is spread by mosquitoes in the tropics, as well ... in Finland and is easily spread by the hands ... the elderly. , Researchers at Aalto University and the ... tests to prevent the spread of one type of ...
(Date:4/15/2014)... cell systems soon could be powering the forklifts used ... and with faster refueling times than ever before, courtesy ... Hydrogen Carriers (HHC). , The goal of the project ... can refuel at low pressure four to five times ... giving hydrogen a competitive advantage over batteries for a ...
(Date:4/14/2014)... swallow, but if you,re over 24 years of age ... cognitive motor performance, according to a new Simon Fraser ... doctoral student, associate professor Mark Blair, Thompson,s thesis supervisor, ... student, deliver the news in a just-published PLOS ... the first social science experiments to rest on big ...
Breaking Biology News(10 mins):Nanocrystalline cellulose modified into an efficient viral inhibitor 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 3Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 4Study says we're over the hill at 24 2
... (SACRAMENTO, Calif.) An international team of scientists led by ... cells is not a one-way street as previously believed. Their ... has a self-correcting mechanism that allows DNA to make a ... appear in the Oct. 23 online issue of the journal ...
... A peer-reviewed study commissioned by NOAA shows the American people ... the coral reefs of the main Hawaiian Islands. ... treasure Hawaii,s coral reefs, even though many never get to ... for oceans and atmosphere and NOAA administrator. "It illustrates the ...
... of Plant Biologists (ASPB) has named 12 plant biology researchers ... Science Master Plant Science Team (MPST). ... research resource that brings together middle and high school students, ... engage in hands-on plant investigations while working with peers at ...
Cached Biology News:UC Davis researchers discover complexities of DNA repair 2US residents say Hawaii's coral reef ecosystems worth $33.57 billion per year 2American Society of Plant Biologists supports science outreach by grad students and postdocs 2American Society of Plant Biologists supports science outreach by grad students and postdocs 3
Mouse polyclonal antibody raised against a partial recombinant WRB. NCBI Entrez Gene ID = 7485...
...
Mouse monoclonal to Casein Kinase 2 beta ( Abpromise for all tested applications). entrezGeneID: 1460 SwissProtID: P13862...
Mouse monoclonal antibody raised against a partial recombinant FAAH. NCBI Entrez Gene ID = FAAH...
Biology Products: